Company intelligence / Profile preview

Rincon Pharmaceuticals

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Rincon Pharmaceuticals is a San Diego-based biotechnology company specializing in the design and development of next-generation antibody-drug conjugates (ADCs) for cancer treatment. The company utilizes a proprietary platform to engineer ADCs with improved stability, potency, and safety profiles compared to traditional conjugates. By focusing on site-specific conjugation and novel payload technologies, Rincon aims to expand the therapeutic window for treating various solid tumors. The company is currently advancing multiple programs through the preclinical stage to address high unmet medical needs in oncology.

Therapeutic areas: Oncology
Modalities: Antibody-drug conjugateMonoclonal antibody
Industry: Biotech

Beyond the preview

Go deeper on Rincon Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rincon Pharmaceuticals.

Explore the full profile